Influenza and Respiratory Syncytial Virus Infections in Pediatric Patients during the COVID-19 Pandemic: A

Aušra Steponavičienė1, Sigita Burokienė1, Inga Ivaškevičienė1

  • 1Clinic of Children's Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.

Insights

Coinfection with respiratory syncytial virus (RSV) or influenza did not worsen outcomes for children with COVID-19. However, RSV and SARS-CoV-2 impacted younger children, while influenza affected older children.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Background:

  • Co-infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with other respiratory pathogens can complicate disease course.
  • Understanding the interplay between COVID-19 and common pediatric respiratory viruses is crucial for effective management.

Purpose of the Study:

  • To determine the rates, characteristics, and outcomes of pediatric patients with SARS-CoV-2, respiratory syncytial virus (RSV), and influenza A/B infections.
  • To investigate the impact of coinfections on disease severity in children.

Main Methods:

  • A single-center prospective cross-sectional study conducted in a pediatric emergency department.
  • Screening of 5127 children for SARS-CoV-2, RSV, and influenza A/B from October 2021 to April 2022.

Main Results:

  • SARS-CoV-2 was detected in 21.0% of children. Coinfection with RSV or influenza A occurred in 7.2% of COVID-19 patients.
  • RSV and SARS-CoV-2 predominantly affected children up to 2 years old, while influenza was more common in children aged 4-10 years.
  • Patients with COVID-19 and coinfection did not exhibit a more severe clinical course compared to those with single RSV or influenza infections. RSV infection was associated with higher hospitalization rates and need for respiratory support.

Conclusions:

  • Coinfection with RSV or influenza does not necessarily increase disease severity in pediatric COVID-19 cases.
  • RSV and SARS-CoV-2 impact younger children, whereas influenza affects older children, indicating age-specific patterns of these viral infections.

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
277
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
777
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
180
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
258
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
1.2K